VIC 2021 Annual Report Executive Summary
2021 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.
VIC Team
Recent Posts
VIC Technology Venture Development Establishes Medical Advisory Board
VIC’s newly formed Medical Advisory Board (MAB) provides VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s opportunity assessment team by reviewing new...
VIC Fellows Spotlight: Kelly Mabry, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
VIN Partner Profile: Carol Reeves
Could you tell us a little bit about your background and experience? I grew up on a tiny farm in Fayetteville, Georgia. Because my family was poor, my siblings and I were always trying to figure out ways to make money....
Nob Hill Therapeutics Announces Strategic Advisory Board to Accelerate Growth
Nob Hill Therapeutics has recruited global thought leaders to its Strategic Advisory Board. Albuquerque, NM - Nob Hill Therapeutics (NHT) is pleased to announce the members of its Strategic Advisory Board. Under the...
Inside UCSF Innovation Ventures with Executive Director, Anthony Francis
Tell us about UCSF and what sets your institution apart? The simple answer to that question would be it’s the scientific research coupled with our focus on practical healthcare. At the University of California, San...
VIC Technology Venture Development Adds Laura Lyons to Board of Directors
Medtech veteran adds further quality, regulatory, and clinical experience FAYETTEVILLE, AR- VIC Technology Venture Development has announced the appointment of Laura Lyons, who brings 20 years of executive leadership...
Nob Hill Therapeutics to Present at Partnership Opportunities in Drug Delivery (PODD) Conference
Nob Hill Therapeutics' Executive Chairman Paul Atkins will be presenting at the Partnership Opportunities in Drug Delivery (PODD) conference during the DryNeb – Advancing Pulmonary Drug Delivery session on Friday,...
VIC Fellows Spotlight: Secondra Holmes, PhD
The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...
Neurexis Therapeutics Awarded NIH Phase I SBIR Grant to Accelerate IND-Enabling Studies of Neuroprotective Therapeutic
A promising approach for preventing cognitive and behavioral impairment following ischemic events such as cardiac arrest and stroke. Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded a...
